WARRINGTON, Pa., Oct. 20, 2016 /PRNewswire/ -- Windtree
Therapeutics, Inc. (Nasdaq: WINT), a biotechnology company
focused on developing aerosolized KL4 surfactant therapies for
respiratory diseases, will host a conference call and webcast
(including a slide presentation) at 8:00
a.m. EDT on Tuesday, October 25,
2016 to provide updates on the AEROSURF® phase 2 clinical
program and the lung deposition study in non-human
primates.
To participate in the live call and take part in the question
and answer session, dial (844) 802-2436 (domestic) or (412)
317-5129 (international). The live webcast, including a slide
presentation, can be accessed at
http://windtreetx.investorroom.com/events .
A replay of the conference call will be accessible one hour
after completion through November 1,
2016 by dialing (877) 344-7529 (domestic) or (412) 317-0088
(international) and referencing conference ID number 10095419. An
archive of the webcast can be accessed on the Company's website at
http://windtreetx.investorroom.com/events.
About Windtree Therapeutics
Windtree Therapeutics,
Inc. is a clinical-stage biotechnology company focused on
developing novel surfactant therapies for respiratory diseases
and other potential applications. Windtree's proprietary technology
platform includes a synthetic, peptide-containing surfactant (KL4
surfactant) that is structurally similar to endogenous pulmonary
surfactant and novel drug-delivery technologies being developed to
enable noninvasive administration of aerosolized KL4
surfactant. Windtree is focused initially on improving the
management of respiratory distress syndrome (RDS) in premature
infants and believes that its proprietary technology may make it
possible, over time, to develop a pipeline of KL4 surfactant
product candidates to address a variety of respiratory diseases for
which there are few or no approved therapies.
For more information, please visit the Company's website at
www.windtreetx.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/windtree-therapeutics-to-host-conference-call-and-webcast-on-tuesday-october-25-2016-to-provide-a-business-update-300348712.html
SOURCE Windtree Therapeutics, Inc.